Acute Respiratory Distress Syndrome (ARDS)
ARDS is acute diffuse inflammatory injury of the alveolar-capillary barrier causing bilateral pulmonary opacities and severe hypoxaemic respiratory failure not fully explained by cardiac failure or fluid overload; treat the trigger while delivering lung-protective critical care and escalating early when oxygenation remains refractory.
In a nutshell
ARDS is acute inflammatory permeability oedema causing bilateral opacities and severe hypoxaemic respiratory failure not fully explained by cardiac failure or fluid overload. Treat the trigger in critical care, use lung-protective ventilation, prone appropriate moderate or severe disease and refer early for refractory respiratory failure or ECMO consideration.
Classic presentation
A patient with pneumonia or sepsis develops rapidly worsening hypoxaemia and bilateral infiltrates despite oxygen, with no single cardiac or fluid explanation for the respiratory failure.
Key points
- ARDS is a syndrome caused by another illness, commonly pneumonia or sepsis, rather than a primary disease of unknown context.
- The diagnostic pattern is acute hypoxaemic respiratory failure, bilateral opacities and no alternative explanation that fully accounts for the oedema.
- Use predicted or ideal body weight for protective tidal-volume calculations, not actual body weight.
- Protective ventilation limits tidal volume and plateau pressure; accept permissive hypercapnia when appropriate rather than causing ventilator-induced injury.
- Prone moderate or severe ARDS early and for prolonged sessions with a trained ICU team.
- Persistent severe gas-exchange failure needs early specialist respiratory-failure or ECMO-centre discussion.
First-line investigation
Arterial blood gas with a PaO2/FiO2 ratio and chest imaging, alongside clinical assessment of the trigger, cardiac function, volume status and other causes of acute hypoxaemia.
Management
Treat the cause and stabilise in critical care
Protect the ventilated lung
Prone and optimise physiology
Refer refractory respiratory failure
Exam traps
- Use predicted or ideal body weight, not actual weight, for tidal volume.
- ARDS is not diagnosed by hypoxaemia alone: bilateral opacities and exclusion of a complete cardiac or fluid explanation are part of the syndrome.
- Do not increase tidal volume simply to normalise carbon dioxide if this breaches lung-protective targets.
- Proning is a prolonged, trained-team ICU intervention with airway, line, pressure-area and haemodynamic risks.
- Do not pursue conservative fluids through shock or hypoperfusion; reassess after initial resuscitation.
- Routine high-frequency oscillation, inhaled nitric oxide and ECCO2R are not generic first-line ARDS treatments.
Illustrations
Key sources
- FICM, Management of acute respiratory distress syndrome in adults: best practice (Current UK FICM best-practice standard covering low tidal-volume ventilation, plateau-pressure limits, conservative fluid management, PEEP, neuromuscular blockade, proning and severe respiratory-failure referral; published 6 June 2024)Published 6 Jun 2024
- FICM/ICS, Guidelines on the management of acute respiratory distress syndrome (UK multidisciplinary ARDS guideline using GRADE methodology; includes protective ventilation, prone positioning, conservative fluids, PEEP, selected neuromuscular blockade and ECMO referral; published July 2018 and reviewed as current by ICS)Published 1 Jul 2018
- FICM/ICS, Guidelines for the Provision of Intensive Care Services V3 (Current UK intensive-care service standard supporting protective ventilation, prone positioning, conservative fluid management, ECMO pathways and avoidance of routine high-frequency oscillation or ECCO2R; published January 2026)Published 28 Jan 2026
- Intensive Care Society, Prone position in adult critical care (UK critical-care guidance on safe prone positioning, staffing, complications and prolonged prone ventilation in severe hypoxaemia)Published 1 Jun 2019
- NICE NG253, Suspected sepsis in people aged 16 or over (Current adult sepsis recognition, investigation, antimicrobial, source-control, monitoring and escalation pathway; published 19 November 2025)Published 19 Nov 2025
- NICE NG250, Pneumonia: diagnosis and management (Current pneumonia assessment, imaging, severity, antibiotic and reassessment pathway; published 2 September 2025)Published 2 Sept 2025
- NICE CG174, Intravenous fluid therapy in adults in hospital (Current NICE assessment, resuscitation, replacement, redistribution, reassessment and monitoring principles for fluid management in hospital)Published 10 Dec 2013
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

